0
0

Safe Medicine Act

12/19/2024, 9:07 AM

Summary of Bill HR 5575

The Safe Medicine Act, also known as Bill 118 hr 5575, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to ensure the safety and effectiveness of prescription medications in the United States.

One key provision of the Safe Medicine Act is the requirement for pharmaceutical companies to conduct thorough testing and clinical trials before bringing a new drug to market. This is intended to prevent harmful or ineffective medications from being prescribed to patients.

Additionally, the bill includes measures to increase transparency in the pharmaceutical industry. This includes requiring drug manufacturers to disclose any potential conflicts of interest and financial ties to healthcare providers. The Safe Medicine Act also aims to improve the monitoring and reporting of adverse reactions to medications. This will help identify any potential safety issues with prescription drugs and allow for swift action to protect patients. Overall, the Safe Medicine Act is focused on promoting the safety and efficacy of prescription medications in the United States. By implementing stricter testing requirements, increasing transparency, and improving monitoring of adverse reactions, this bill seeks to protect the health and well-being of American consumers.

Congressional Summary of HR 5575

Safe Medicine Act

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs must jointly develop and implement a strategy to increase the domestic production of essential medicines, medical countermeasures, and critical inputs.

If the Food and Drug Administration determines that a drug or active pharmaceutical ingredient is manufactured in a country that may be producing contaminated drugs or ingredients due to systemic manufacturing-related problems, the labeling for that drug or ingredient must have a boxed warning about the potential for contamination.

For government procurement purposes, the President's authority to waive certain purchasing requirements that discriminate against foreign products may not be used to waive any preferences for goods that are essential medicines, medical countermeasures, or critical inputs.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill HR 5575

Bill HR 5575 is currently in the status of Bill Introduced since September 19, 2023. Bill HR 5575 was introduced during Congress 118 and was introduced to the House on September 19, 2023.  Bill HR 5575's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 5575

Total Number of Sponsors
2
Democrat Sponsors
0
Republican Sponsors
2
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 5575

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health
- Chemical and biological weapons
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Emergency medical services and trauma care
- Health technology, devices, supplies
- Infectious and parasitic diseases
- Manufacturing
- Medical tests and diagnostic methods
- Military medicine
- Military procurement, research, weapons development
- Nuclear weapons
- Public contracts and procurement
- Strategic materials and reserves
- Trade agreements and negotiations
- Veterans' medical care
- Worker safety and health

Alternate Title(s) of Bill HR 5575

Safe Medicine Act
Safe Medicine Act
To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.

Comments

Sponsors and Cosponsors of HR 5575

Bill Posey
Bill Posey
FloridaRepublican

Latest Bills

Providing amounts for the expenses of the Committee on Ethics in the One Hundred Nineteenth Congress.
Bill HRES 131December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Central Yukon Record of Decision and Approved Resource Management Plan".
Bill HJRES 106December 12, 2025
Expressing the sense of the House of Representatives in condemning the Government of the People's Republic of China for its harassment and efforts to intimidate American citizens and other individuals on United States soil with the goal of suppressing speech and narratives the People's Republic of China finds unwelcome.
Bill HRES 130December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "North Dakota Field Office Record of Decision and Approved Resource Management Plan".
Bill HJRES 105December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Miles City Field Office Record of Decision and Approved Resource Management Plan Amendment".
Bill HJRES 104December 12, 2025
Providing amounts for the expenses of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party in the One Hundred Nineteenth Congress.
Bill HRES 104December 12, 2025
Critical Access for Veterans Care Act
Bill S 1868December 12, 2025
OATH Act of 2025
Bill S 1665December 12, 2025
A bill to extend the authority for modifications to the Second Division Memorial in the District of Columbia.
Bill S 1353December 12, 2025
Saving Our Veterans Lives Act of 2025
Bill S 926December 12, 2025